3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
1
Interventions
Sunitinib
16
exemestane
11
Afatinib
11
palbociclib
10
Rituximab
10
Bevacizumab
10
Erlotinib Hydrochloride
9
Leuprolide
8
Radiotherapy
7
Drug Therapy
7
Axitinib
7
avelumab
6
Letrozole
6
Capecitabine
6
Blood Specimen Collection
6
enzalutamide
5
Trastuzumab
5
Surveys and Questionnaires
5
Standard of Care
5
Docetaxel
5
Aromatase Inhibitors
5
lorlatinib
4
Specimen Handling
4
Radiation
4
Mammography
4
Crizotinib
4
Anastrozole
4
Abiraterone Acetate
4
temsirolimus
3
talazoparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Has results
×
larotrectinib
×
Clear all
NCT05236257
2024-12-10
EPI VITRAKVI
Bayer
Completed
93 enrolled
14 charts